StockNews.com initiated coverage on shares of Titan Pharmaceuticals (NASDAQ:TTNP – Free Report) in a research note published on Monday morning. The firm issued a sell rating on the specialty pharmaceutical company’s stock. Titan Pharmaceuticals Price Performance NASDAQ:TTNP opened at $7.10 on Monday. The firm’s 50-day moving average price is $7.34 and its 200-day moving average […]
StockNews.com began coverage on shares of Titan Pharmaceuticals (NASDAQ:TTNP – Free Report) in a research report sent to investors on Tuesday. The brokerage issued a sell rating on the specialty pharmaceutical company’s stock. Titan Pharmaceuticals Price Performance NASDAQ TTNP opened at $0.42 on Tuesday. Titan Pharmaceuticals has a 12 month low of $0.25 and a […]
StockNews.com began coverage on shares of Titan Pharmaceuticals (NASDAQ:TTNP – Free Report) in a research report released on Tuesday morning. The brokerage issued a sell rating on the specialty pharmaceutical company’s stock. Titan Pharmaceuticals Price Performance TTNP opened at $0.42 on Tuesday. The business has a 50 day moving average of $0.35 and a 200-day […]
StockNews.com began coverage on shares of Titan Pharmaceuticals (NASDAQ:TTNP – Free Report) in a research report sent to investors on Thursday. The firm issued a sell rating on the specialty pharmaceutical company’s stock. Titan Pharmaceuticals Price Performance TTNP opened at $0.37 on Thursday. Titan Pharmaceuticals has a 12 month low of $0.31 and a 12 […]
Titan Pharmaceuticals, Inc. (NASDAQ:TTNP – Get Free Report) was the recipient of a significant growth in short interest in October. As of October 31st, there was short interest totalling 93,000 shares, a growth of 49.5% from the October 15th total of 62,200 shares. Based on an average daily volume of 37,800 shares, the days-to-cover ratio […]